1. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
   Sebastian Meller et al, 2016, Epigenetics CrossRef
2. MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
   A. Cannistraci et al, 2022, Oncogene CrossRef